Difference between revisions of "Enventure"
Jump to navigation
Jump to search
imported>Komal |
imported>Komal |
||
Line 1: | Line 1: | ||
Enventure is a non-profit healthcare-focused organization and accelerator. It hosts numerous free events about entrepreneurship, specifically regarding medical technology businesses throughout the year. Its accelerator-course hybrid program, bioventures, is a 10 week course every spring for students to develop hands-on experience building a biotechnology company from ideation to first-round investment. Enventure provides connections to mentors, speakers, and intellectual property. The last day of the course is a pitch day, in which the teams present to investors and receive a pass/fail score. [http://www.enventure.org/] | Enventure is a non-profit healthcare-focused organization and accelerator. It hosts numerous free events about entrepreneurship, specifically regarding medical technology businesses throughout the year. Its accelerator-course hybrid program, bioventures, is a 10 week course every spring for students to develop hands-on experience building a biotechnology company from ideation to first-round investment. Enventure provides connections to mentors, speakers, and intellectual property. The last day of the course is a pitch day, in which the teams present to investors and receive a pass/fail score. [http://www.enventure.org/] | ||
+ | |||
+ | ==Leadership== | ||
+ | |||
+ | ==Contact== |
Revision as of 13:26, 16 March 2016
Enventure is a non-profit healthcare-focused organization and accelerator. It hosts numerous free events about entrepreneurship, specifically regarding medical technology businesses throughout the year. Its accelerator-course hybrid program, bioventures, is a 10 week course every spring for students to develop hands-on experience building a biotechnology company from ideation to first-round investment. Enventure provides connections to mentors, speakers, and intellectual property. The last day of the course is a pitch day, in which the teams present to investors and receive a pass/fail score. [1]